Cytogen, Inc. (KOSDAQ:217330)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,010.00
-15.00 (-0.37%)
At close: Jun 10, 2026

Cytogen Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
12,98110,99131,20154,83815,87830,288
Short-Term Investments
12,02420,52210,06549.4650.435,515
Trading Asset Securities
----1,993-
Cash & Short-Term Investments
25,00631,51341,26654,88717,92235,803
Cash Growth
-35.26%-23.64%-24.82%206.26%-49.94%-
Accounts Receivable
6,3956,0813,700473.96588.2388.9
Other Receivables
370.39566.58836.34259.88164.15137.48
Receivables
6,7656,6474,536733.84752.38226.38
Inventory
4,2914,3891,72325.3131.47-
Prepaid Expenses
170.84155.94184.8234.71186.7373.13
Other Current Assets
1,317522.66368.71122.29396.767,487
Total Current Assets
37,55043,22848,07956,00319,38943,589
Property, Plant & Equipment
6,5326,3766,8284,9803,1042,808
Long-Term Investments
1,5571,5572,4895,5277,3317,321
Goodwill
4,8254,8254,8252,7235,712-
Other Intangible Assets
4,9695,0558,6244,8305,3101,496
Long-Term Deferred Tax Assets
706.56691.24884.61---
Other Long-Term Assets
899.71507.32748.49386.96375.1313.75
Total Assets
57,04062,24072,47874,45041,22055,528
Accounts Payable
2,1823,4571,666206.64189.2112.63
Accrued Expenses
781.44614.95843.76730.431,006376.4
Short-Term Debt
3,3474,771327.927,98025,7583,280
Current Portion of Leases
429428.71917556.4474.98442.66
Other Current Liabilities
4,1815,477960.51,2746,5022,579
Total Current Liabilities
10,92114,7494,71510,74733,9306,791
Long-Term Debt
11,04610,71513,2778,371-20,445
Long-Term Leases
585.93364.73349.93669.13191.3456.46
Pension & Post-Retirement Benefits
262.77139.93235.5937.0552.62191.07
Long-Term Deferred Tax Liabilities
---549.23838.98-
Other Long-Term Liabilities
114.03279.034,958721.58551.384,635
Total Liabilities
22,92926,24723,53521,09535,56432,519
Common Stock
11,56511,56511,56511,1398,9342,947
Additional Paid-In Capital
116,926117,434118,236107,52350,75954,635
Retained Earnings
-98,804-97,532-85,189-68,072-52,302-33,531
Treasury Stock
-3,234-3,234-3,234-3,234-3,234-3,234
Comprehensive Income & Other
7,2167,3297,2055,9981,5002,192
Total Common Equity
33,66935,56248,58353,3555,65623,009
Minority Interest
441.89430.51359.78---
Shareholders' Equity
34,11135,99348,94353,3555,65623,009
Total Liabilities & Equity
57,04062,24072,47874,45041,22055,528
Total Debt
15,40816,27914,87217,57626,42424,624
Net Cash (Debt)
9,59815,23326,39537,311-8,50211,179
Net Cash Growth
-59.29%-42.29%-29.26%---
Net Cash Per Share
416.12660.311168.852040.21-481.37659.73
Filing Date Shares Outstanding
23.1323.1323.0722.2217.8117.5
Total Common Shares Outstanding
23.1323.1323.0722.2217.8117.5
Working Capital
26,62928,47943,36445,256-14,54136,798
Book Value Per Share
1455.621537.712105.942401.36317.611314.64
Tangible Book Value
23,87525,68235,13345,803-5,36521,513
Tangible Book Value Per Share
1032.181110.461522.942061.45-301.261229.19
Land
302.68286.98294257.88--
Buildings
3,1742,1952,2491,973--
Machinery
4,7894,6442,080852.03969.67432.63
Construction In Progress
--26.41465.06507.95